Greenberg PD - Search Results

1

New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies.

Schmitt TM, Stromnes IM, Chapuis AG, Greenberg PD. Schmitt TM, et al. Among authors: greenberg pd. Clin Cancer Res. 2015 Dec 1;21(23):5191-7. doi: 10.1158/1078-0432.CCR-15-0860. Epub 2015 Oct 13. Clin Cancer Res. 2015. PMID: 26463711 Free PMC article. Review.

2

Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.

Kern DE, Klarnet JP, Cheever MA, Greenberg PD. Kern DE, et al. Among authors: greenberg pd. Cancer Res. 1990 Oct 1;50(19):6256-63. Cancer Res. 1990. PMID: 2144789

3

Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.

Treisman J, Higuchi CM, Thompson JA, Gillis S, Lindgren CG, Kern DE, Ridell SR, Greenberg PD, Fefer A. Treisman J, et al. Among authors: greenberg pd. Cancer Res. 1990 Feb 15;50(4):1160-4. Cancer Res. 1990. PMID: 2153452

4

Antigen-specific cultured T cells can mediate tumor therapy and provide long-term immunologic memory in vivo.

Cheever MA, Klarnet JP, Peace DJ, Greenberg PD. Cheever MA, et al. Among authors: greenberg pd. Prog Clin Biol Res. 1987;244:49-58. Prog Clin Biol Res. 1987. PMID: 3498958

5

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients.

Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, Manley SA, Lupton SD, Overell RW, Reynolds TC, Corey L, Greenberg PD. Riddell SR, et al. Among authors: greenberg pd. Nat Med. 1996 Feb;2(2):216-23. doi: 10.1038/nm0296-216. Nat Med. 1996. PMID: 8574968 Clinical Trial.

6

Prospects for adoptive T cell therapy.

Yee C, Riddell SR, Greenberg PD. Yee C, et al. Among authors: greenberg pd. Curr Opin Immunol. 1997 Oct;9(5):702-8. doi: 10.1016/s0952-7915(97)80052-0. Curr Opin Immunol. 1997. PMID: 9368780 Review.

7

Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses.

Yee C, Greenberg P. Yee C, et al. Nat Rev Cancer. 2002 Jun;2(6):409-19. doi: 10.1038/nrc820. Nat Rev Cancer. 2002. PMID: 12189383 Review. No abstract available.

8

Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction.

Ho WY, Blattman JN, Dossett ML, Yee C, Greenberg PD. Ho WY, et al. Among authors: greenberg pd. Cancer Cell. 2003 May;3(5):431-7. doi: 10.1016/s1535-6108(03)00113-2. Cancer Cell. 2003. PMID: 12781360 Free article. Review.

9

Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection.

Dittmer U, He H, Messer RJ, Schimmer S, Olbrich AR, Ohlen C, Greenberg PD, Stromnes IM, Iwashiro M, Sakaguchi S, Evans LH, Peterson KE, Yang G, Hasenkrug KJ. Dittmer U, et al. Among authors: greenberg pd. Immunity. 2004 Mar;20(3):293-303. doi: 10.1016/s1074-7613(04)00054-8. Immunity. 2004. PMID: 15030773 Free article.

10

Cancer immunotherapy: a treatment for the masses.

Blattman JN, Greenberg PD. Blattman JN, et al. Among authors: greenberg pd. Science. 2004 Jul 9;305(5681):200-5. doi: 10.1126/science.1100369. Science. 2004. PMID: 15247469 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters